Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NEO
NEOGENOMICS, INC.
NASDAQ
$18.05
▼ DOWN 3.17% (-0.59)

KEY STATISTICS

Market Cap$463.79 M
52w High$19.76
52w Low$7.07
Dividend Yield0.75%
FrequencySpecial
P/E138.85
Volume1.72M
Shares Out.25.70M

COMPANY

LEADERSHIP

Anthony Zook
CHIEF EXECUTIVE
Anthony Zook

COMPENSATION 2026

Salary$601,539
Stock Awards$3,999,997
Incentive Plan Pay$513,400
All Other Comp.$13,921
Total$9,127,092

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 16, 2004
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
2,500

PRICE TARGET

Target High$25.00
Target Low$19.00
Target Median$22.00
Target Consensus$22.00

UPCOMING EARNINGS

DateOct 27, 2026
DayTuesday
Rev. Est.$205.89M
OCT
27
TUE

SPLIT RECORD

DATETYPERATIO
2003-04-16Reverse1:100
2000-11-17Forward4:1

PRICE

$18.05 ▼ DOWN 3.17% (−$0.59)
OVERLAYS
$18.00$18.25$18.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM18.05

About NeoGenomics, Inc.

https://www.neogenomics.com ↗

NeoGenomics, Inc. operates global cancer-focused laboratories providing clinical and pharma testing services—including cytogenetics, molecular, and immunohistochemistry—to healthcare providers, researchers, and pharmaceutical clients.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT NEOGENOMICS, INC. IS KNOWN FOR

RaDaR ST for MRD
RaDaR ST for MRD

RaDaR ST is an NGS-based liquid biopsy test by NeoGenomics for detecting minimal residual disease to enable early cancer recurrence detection and personalized treatment, launching in early 2026 for head and neck and certain breast cancers.

COMPETITORS

COMPETITOR
ADPT COMPARE
GH COMPARE
NTRA COMPARE
QGEN COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Commercial Insurance$32.47M $31.42M ▼$30.94M ▼$36.27M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
173
LISTED HERE
26
RANKED BY POSITION SIZE
XSMH.TO
0.12% · 7.9M
FBT
4.00% · 6.4M
VTS.AX
0.00% · 4.2M
SPSM
0.13% · 1.2M
SCHA
0.05% · 621.2K
DFMC
0.10% · 427.5K
JMEE
0.25% · 393.7K
MGNR
0.68% · 371.0K
PRFZ
0.14% · 211.9K
PSC
0.14% · 205.2K
AVSC
0.09% · 154.3K
NUSC
0.18% · 138.0K
XRSG.L
0.08% · 120.4K
LFSC
1.22% · 85.6K
FESM
0.02% · 75.9K
RSSL
0.08% · 62.8K
ISMD
0.24% · 47.8K
WSCSRI.SW
0.08% · 40.1K
EES
0.06% · 25.3K
GSSC
0.03% · 19.1K
ZSML.TO
0.13% · 12.8K
SMDX
0.15% · 11.7K
MKTN
0.14% · 11.0K
RFLR
0.20% · 10.5K
RTWP.L
0.08% · 9.8K
URTY
0.03% · 5.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
444
TOP 12 OF 444 · RANKED BY POSITION SIZE
Blackrock, Inc.
20.9M sh · $304.47M
Blackrock Inc.
19.7M sh · $272.82M
Vanguard Group Inc
13.9M sh · $107.34M
First Light Asset Management, LLC
12.3M sh · $179.16M
First Trust Advisors LP
10.1M sh · $147.55M
Greenhouse Funds Lllp
9.1M sh · $67.52M
Millennium Management LLC
6.0M sh · $46.12M
Braidwell LP
5.6M sh · $41.68M
State Street Corp
5.4M sh · $78.26M
D. E. Shaw & Co., Inc.
5.3M sh · $62.3M
Macquarie Management Holdings, Inc.
5.0M sh · $73.5M
Deerfield Management Company, L.P. (Series C)
4.4M sh · $34.33M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book5
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2025-05-07
 Dwight Evans
Dwight Evans
Sale (Full)
2022-03-30
 Deborah K. Ross
Deborah K. Ross
Purchase
2021-12-30
 Bob Gibbs
Bob Gibbs
Sale (Full)
2021-11-09

INSIDER TRADES

★
OFFICER: PRES & CHIEF OPERATING OFFICER
Stone Warren
Purchase · 28.1K shares
2026-08-21
★
OFFICER: PRES & CHIEF OPERATING OFFICER
Stone Warren
Sale · 11.1K shares
2026-08-21
★
OFFICER: PRES & CHIEF OPERATING OFFICER
Stone Warren
Sale · 28.1K shares
2026-08-21
★
OFFICER: CHIEF ACCOUNTING OFFICER
Aunan Greg D
Sale · 20.0K shares
2026-08-04

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OVERWEIGHT 2
OUTPERFORM 1
6 GRADES IN THE LAST 12 MONTHS
Needham BUY Benchmark BUY Leerink Partners OUTPERFORM TD Cowen BUY Piper Sandler OVERWEIGHT Stephens & Co. OVERWEIGHT

SECTORS PEERS

PEERPRICE
ACRS$6.01COMPARE
ARCT$15.19COMPARE
TKNO$7.12COMPARE
SGMT$10.55COMPARE
SMTI$34.57COMPARE
XGN$7.39COMPARE
QTRX$2.64COMPARE
HUMA$0.65COMPARE